Chengdu

300841.SZ

Tags: CN Healthcare Biotechnology

Chengdu Kanghua Biological Products Co., Ltd. Price (300841.SZ)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

133,747,266

(0.1703)%

Market Cap of Chengdu (300841.SZ)

Market cap:

As of , 300841.SZ has a market cap of . This makes 300841.SZ the 1812th most valuable company in the CN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials; and human H5N1 influenza vaccine that completed pre-clinical studies. In addition, it exports its products. The company was founded in 2004 and is based in Chengdu, Ch... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $44.01-79
Market Cap 7.83B
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. Wennian Wu
IPO Date: June, 16, 2020
Country: CN
Currency: CNY
Headquaters: No Data
Employees: 672

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: